Results 1 to 10 of about 7,304 (114)
Inflammatory Signatures of Graves’ Orbitopathy: Linking Thyroid Autoimmunity, Disease Activity, and Novel Hematological Biomarkers [PDF]
DiagnosticsBackground: Graves’ disease is an autoimmune thyroid disorder that may be accompanied by systemic inflammation and Graves’ orbitopathy. This study evaluated the relationship between readily available hematological inflammatory markers and orbitopathy in ...
Sadettin Ozturk +1 more
doaj +2 more sources
Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
Frontiers in Endocrinology, 2017 IntroductionGraves’ orbitopathy is the extra thyroidal manifestation of Graves’ disease and the most common cause of exophthalmos. It is also known as thyroid-associated orbitopathy (TAO) as it occasionally occurs in euthyroid or hypothyroid patients ...
Vibhor Wadhwa, Gitanjali Bajaj
exaly +3 more sources
Case Reports of Teprotumumab as Treatment for Monoclonal Antibody-Induced Thyroid Orbitopathy [PDF]
ReportsBackground and Clinical Significance: Targeted biologic therapies, especially monoclonal antibodies (mAbs) such as nivolumab and alemtuzumab, have revolutionized treatment for malignancies and autoimmune conditions but can cause rare immune-related ...
Jared Moon +4 more
doaj +2 more sources
Effectiveness of Selenium Supplementation in the Treatment of Graves–Basedow Disease: A Scoping Review [PDF]
Medical SciencesBackground: Graves–Basedow disease (GBD) is an autoimmune thyroid disorder characterized by loss of tolerance to the thyrotropin receptor, with clinical manifestations such as a hyperadrenergic state, goiter, orbitopathy, and myxedema, inter alia ...
Hernando Vargas-Uricoechea +5 more
doaj +2 more sources
Steroid-resistant Graves' orbitopathy: Therapeutic options [PDF]
Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2023 Graves orbitopathy is the most common extrathyroidal manifestation of autoimmune hyperthyroidism, although it can rarely occur in euthyroid and hypothyroid patients.
Klet Sanja +6 more
doaj +1 more source
Frontiers in Endocrinology, 2022 BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed.
Irene Campi +16 more
doaj +1 more source
Endokrynologia Polska, 2021 On March 11, 2020, the World Health Organisation (WHO) observed the scale of epidemic risk and declared the state of the COVID-19 pandemic. Most countries, including Poland, implemented national and local emergency management plans to deal with the ...
Beata Matyjaszek-Matuszek +5 more
doaj +1 more source
Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
Frontiers in Endocrinology, 2022 There is currently no universally accepted name for inflammatory disease of the eye and orbit associated with thyroid autoimmune disease. Variability in terminology impedes the evaluation of scientific literature and clinical collaboration and can affect
Lilly H. Wagner +5 more
doaj +1 more source
Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
Clinical Case Reports, 2022 A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine.
Solange Grunenwald +4 more
doaj +1 more source
Acta Medica Indonesiana, 2023 We report a woman, 45th year old with Graves’ disease treated with anti-thyroid drug (thiamazole). She came to our clinic with severe and active Graves’ orbitopathy.
Laurentius Aswin Pramono
doaj +2 more sources